Provided By GlobeNewswire
Last update: Sep 18, 2024
ATLANTA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces the onboarding of the first infertility medical clinic customers to offer its FemaSeed infertility treatment to patients in California and Florida.
Read more at globenewswire.comNASDAQ:FEMY (4/28/2025, 8:07:10 PM)
1.16
-0.07 (-5.69%)
Find more stocks in the Stock Screener